Previous 10 | Next 10 |
2023-05-04 15:25:08 ET National Research Corporation (NRC) Q1 2023 Earnings Conference Call May 03, 2023 11:00 AM ET Company Participants Kevin Karas - CFO Linda Stacy - VP, Finance Conference Call Participants Presentation Operator Hello ...
MALVERN, Pa., May 03, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced today their partic...
2023-05-02 17:15:02 ET National Research press release ( NASDAQ: NRC ): Q1 GAAP EPS of $0.28. Revenue of $36.47M (-5.0% Y/Y). For further details see: National Research GAAP EPS of $0.28, revenue of $36.47M
LINCOLN, Neb, May 02, 2023 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the first quarter 2023. Regarding the Company’s 2023 first quarter, Kevin Karas, Chief Financial Officer, said, “We remain focused on enabling h...
A Media Snippet accompanying this announcement is available by clicking on the image or link below: MALVERN, Pa., May 02, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products...
MALVERN, Pa., May 01, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced today the ad...
MALVERN, Pa., April 28, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that Unite...
MALVERN, Pa., April 25, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that it pl...
Lincoln, Nebraska, April 18, 2023 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ/:NRC) today announced that it will provide an online web simulcast of its 2023 first quarter earnings conference call on Wednesday, May 3, 2023. The Company’s results for the 2023 first quarter will...
MALVERN, Pa., April 13, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced a health...
News, Short Squeeze, Breakout and More Instantly...
National Research Corporation Company Name:
NRC Stock Symbol:
NASDAQ Market:
National Research Corporation Website:
MALVERN, Pa., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, is partnering with non-profit This Is My Bra...
MALVERN, Pa., July 31, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that the management team wil...
MALVERN, Pa., July 30, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that it entered into a debt ...